IMPAIRED CHOLESTEROL EFFLUX INTO HDL2 IN METABOLIC SYNDROME

被引：0
|
作者：
Paavola, T. [1 ,2 ,3 ,4 ]
Kuusisto, S. M. [1 ,2 ,3 ,4 ]
Kangas-Kontio, T. [1 ,2 ,3 ,4 ]
Metso, J. [5 ,6 ]
Jauhiainen, M. [5 ,6 ]
Hannuksela, M. L. [1 ,2 ,3 ,4 ]
Savolainen, M. J. [1 ,2 ,3 ,4 ]
Kakko, S. [1 ,2 ,3 ,4 ]
Salonurmi, T. [1 ,2 ,3 ,4 ]
机构：
[1] Univ Oulu, Dept Internal Med, SF-90220 Oulu, Finland
[2] Univ Oulu, Bioctr Oulu, Oulu, Finland
[3] Univ Oulu, Med Res Ctr, Oulu, Finland
[4] Oulu Univ Hosp, Oulu, Finland
[5] Natl Inst Hlth & Welf, Publ Hlth Genom Unit, Helsinki, Finland
[6] Biomedicum, Helsinki, Finland
来源：
ATHEROSCLEROSIS | 2014年 / 235卷 / 02期
关键词：
D O I：
10.1016/j.atherosclerosis.2014.05.534
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
EAS-0578
引用
收藏
页码：E183 / E184
页数：2
相关论文
共 50 条
  • [1] Impaired HDL cholesterol efflux in metabolic syndrome is unrelated to glucose tolerance status: the CODAM study
    Annema, Wijtske
    Dikkers, Arne
    de Boer, Jan Freark
    van Greevenbroek, Marleen M. J.
    van der Kallen, Carla J. H.
    Schalkwijk, Casper G.
    Stehouwer, Coen D. A.
    Dullaart, Robin P. F.
    Tietge, Uwe J. F.
    SCIENTIFIC REPORTS, 2016, 6
  • [2] Impaired HDL cholesterol efflux in metabolic syndrome is unrelated to glucose tolerance status: the CODAM study
    Wijtske Annema
    Arne Dikkers
    Jan Freark de Boer
    Marleen M. J. van Greevenbroek
    Carla J. H. van der Kallen
    Casper G. Schalkwijk
    Coen D. A. Stehouwer
    Robin P. F. Dullaart
    Uwe J. F. Tietge
    Scientific Reports, 6
  • [3] Impaired HDL2-mediated cholesterol efflux is associated with metabolic syndrome in families with early onset coronary heart disease and low HDL-cholesterol level
    Paavola, Timo
    Kuusisto, Sanna
    Jauhiainen, Matti
    Kakko, Sakari
    Kangas-Kontio, Tiia
    Metso, Jari
    Soininen, Pasi
    Ala-Korpela, Mika
    Bloigu, Risto
    Hannuksela, Minna L.
    Savolainen, Markku J.
    Salonurmi, Tuire
    PLOS ONE, 2017, 12 (02):
  • [4] Oxidatively modified HDL2 is superior to native HDL2 in providing cholesterol to lymphocytes
    Sakuma, N.
    Saeki, T.
    Kobayashi, K.
    Mukai, S.
    Sakata, S.
    Mizuno, H.
    Kato, T.
    Kunimatsu, M.
    Kimura, G.
    ATHEROSCLEROSIS SUPPLEMENTS, 2006, 7 (03) : 528 - 528
  • [5] SELECTIVE REDUCTION OF HDL2 CHOLESTEROL USING PROBUCOL IN PATIENTS WITH HIGH-LEVELS HDL2 CHOLESTEROL AND ABNORMAL TRANSPORT OF CHOLESTEROL ESTERS
    不详
    MEDICINA CLINICA, 1990, 95 (08): : U302 - U303
  • [6] INCREASE IN HDL2 CHOLESTEROL WITH PHENYTOIN THERAPY
    BELL, HH
    DITTMEIER, GE
    ARTERIOSCLEROSIS, 1985, 5 (05): : A514 - A514
  • [7] Fibroblast cholesterol efflux to plasma from metabolic syndrome subjects is not impaired
    Dullaart, R. P. F.
    Groen, A. K.
    Dallinga-Thie, G. M.
    de Vries, R.
    Sluiter, W. J.
    van Tol, A.
    DIABETOLOGIA, 2007, 50 : S11 - S11
  • [8] A COMPARISON OF 2 MICROMETHODS FOR THE DETERMINATION OF HDL2 AND HDL3 CHOLESTEROL
    FARISH, E
    FLETCHER, CD
    CLINICA CHIMICA ACTA, 1983, 129 (02) : 221 - 228
  • [9] NONENZYMATIC GLYCOSYLATION OF HDL AND IMPAIRED HDL-RECEPTOR MEDIATED CHOLESTEROL EFFLUX
    DUELL, PB
    ORAM, JF
    BIERMAN, EL
    DIABETES, 1991, 40 (03) : 377 - 384
  • [10] CHOLESTEROL EFFLUX TO APOA-I, HDL2, AND SERUM FROM MACROPHAGES ISOLATED FROM LOW AND HIGH HDL SUBJECTS
    Vikstedt, R.
    Nakanishi, S.
    Soderlund, S.
    Ehnholm, C.
    Kovanen, P.
    Jauhiainen, M.
    Taskinen, M. -R.
    ATHEROSCLEROSIS SUPPLEMENTS, 2008, 9 (01) : 21 - 21
12345